| (Values in U.S. Thousands) | Apr, 2025 | Apr, 2025 | Apr, 2025 | Apr, 2025 | Apr, 2025 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Mgc Pharmaceuticals Limited (MXC.LN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
22.000 unch (unch) 04/03/24 [LSE]
N/A x N/A N/A x N/A
Post-market 22.000 unch (unch) -
for Wed, Apr 3rd, 2024
Argent Biopharma Ltd is an innovative drug discovery company that addresses unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector. Its products includes CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development.